# OnCo record abbott-realtime-idh1 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/abbott-realtime-idh1/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "abbott-realtime-idh1" ;
  schema:name "Abbott RealTime IDH1"@en ;
  schema:description "The FDA-approved test that finds an IDH1 mutation in acute myeloid leukaemia or myelodysplastic syndrome, which makes a person eligible for an IDH1 inhibitor."@en ;
  schema:url <https://onco.cc/drugs/abbott-realtime-idh1/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P170041>, <https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "PCR companion diagnostic test (IDH1 mutations, blood or bone marrow)" ;
  schema:alternateName "Abbott RealTime IDH1" ;
  onco:approval "US 2018: Companion diagnostic for ivosidenib in acute myeloid leukaemia (IDH1 R132 mutations)", "US 2022: Companion diagnostic for olutasidenib in acute myeloid leukaemia", "US 2023: Companion diagnostic for ivosidenib in myelodysplastic syndromes" ;
  onco:related <https://onco.cc/drugs/abbott-realtime-idh2/>, <https://onco.cc/biomarkers/idh1-r132/> ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:targets <https://onco.cc/targets/idh/> ;
  onco:drugs <https://onco.cc/drugs/ivosidenib/>, <https://onco.cc/drugs/olutasidenib/> ;
  onco:companies <https://onco.cc/companies/abbott/> ;
  onco:terms <https://onco.cc/terms/pcr/>, <https://onco.cc/terms/companion-diagnostic-term/> .